Your browser doesn't support javascript.
loading
Virtual Reality Exposure Therapy for Treating Fear of Contamination Disorders: A Systematic Review of Healthy and Clinical Populations.
Ferraioli, Francesca; Culicetto, Laura; Cecchetti, Luca; Falzone, Alessandra; Tomaiuolo, Francesco; Quartarone, Angelo; Vicario, Carmelo Mario.
Afiliación
  • Ferraioli F; Department of Cognitive Science, University of Messina, 98121 Messina, Italy.
  • Culicetto L; Department of Cognitive Science, University of Messina, 98121 Messina, Italy.
  • Cecchetti L; IMT School for Advanced Studies Lucca, 55100 Lucca, Italy.
  • Falzone A; Department of Cognitive Science, University of Messina, 98121 Messina, Italy.
  • Tomaiuolo F; Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.
  • Quartarone A; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Centro Neurolesi Bonino-Pulejo, 98124 Messina, Italy.
  • Vicario CM; Department of Cognitive Science, University of Messina, 98121 Messina, Italy.
Brain Sci ; 14(5)2024 May 17.
Article en En | MEDLINE | ID: mdl-38790488
ABSTRACT
Virtual Reality Exposure Therapy (VRET), particularly immersive Virtual Reality Exposure Therapy (iVRET), has gained attraction as an innovative approach in exposure therapy (ET), notably for some anxiety disorders with a fear of contamination component, such as spider phobia (SP) and obsessive-compulsive disorder (OCD). This systematic work investigates iVRET's effectiveness in modulating disgust emotion-a shared aberrant feature across these disorders. Recent reviews have evaluated VRET's efficacy against in vivo ET. However, emerging evidence also highlights iVRET's potential in diminishing atypical disgust and related avoidance behaviors, expanding beyond traditional fear-focused outcomes. Our systematic synthesis, adhering to PRISMA guidelines, aims to fill this gap by assessing iVRET's efficacy in regulating disgust emotion within both clinical and at-risk populations, identified through standardized questionnaires and subjective disgust ratings. This research analyzes data from eight studies on clinical populations and five on healthy populations, offering an insight into iVRET's potential to mitigate the aberrant disgust response, a common transdiagnostic feature in varied psychopathologies. The findings support iVRET's clinical relevance in disgust management, providing evidence for a broader therapeutic application of iVRET and pointing out the need for more focused and complete investigations in this emergent field.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Brain Sci Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Brain Sci Año: 2024 Tipo del documento: Article